Centinel Spine® announced the recent publication of a research study on its STALIF C-Ti® product in the Journal of Surgery & Anesthesia Research: “Preliminary 12-Month Safety and Efficacy Outcomes for the Treatment of Cervical Radiculopathy and Myelopathy with the Stalif-C Integrated Interbody Fusion Device.” Jad G. Khalil, MD of Michigan Orthopaedic Surgeons believes this study will be very important in influencing fusion device selection.
